Announcement on Approval of the Application for Market Authorization of Additional Indications for Peginterferon alfa-2b Injection

About this update from Xiamen Amoytop Biotech Co., Ltd. Class A

Announcement on Approval of the Application for Market Authorization of Additional Indications for Peginterferon alfa-2b InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xiamen Amoytop Biotech Co., Ltd. Class A